Literature DB >> 22371013

Changes caused by haloperidol are blocked by music in Wistar rat.

Inmaculada Tasset1, Ismael Quero, Ángel D García-Mayórgaz, Manuel Causse del Río, Isaac Túnez, Pedro Montilla.   

Abstract

This study sought to evaluate the effect of classical music, using Mozart's sonata for two pianos (K. 448), on changes in dopamine (DA) levels in the striatal nucleus (SN), prefrontal cortex (PFC) and mesencephalon, and on prolactin (PRL) and corticosterone secretion in adult male Wistar rats. Rats were divided into four groups: (1) control, (2) haloperidol treatment (single dose of 2 mg/kg s.c.), (3) music (two 2-h sessions per day) and (4) haloperidol plus music. Rats were sacrificed 2 h after haloperidol injection. Music prompted a fall in plasma PRL and corticosterone levels in healthy rats (P < 0.05) and prevented the increase in levels triggered by haloperidol (P < 0.001). Moreover, exposure to music was associated with a significant increase in DA levels in all groups, with the increase being particularly marked in PFC and SN (P < 0.001). Haloperidol is a recognised D2 receptor antagonist, and these findings suggest that music, by contrast, enhances DA activity and turnover in the brain. The results obtained here bear out reports that music triggers a reduction in systolic pressure and an increase in mesencephalon dopamine levels in human and rats treated with ecstasy, through a calmodulin-dependent system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22371013     DOI: 10.1007/s13105-011-0129-8

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  23 in total

1.  Changes of the neurotransmitter serotonin but not of hormones during short time music perception.

Authors:  S Evers; B Suhr
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

Review 2.  Music as therapy.

Authors:  Kathi J Kemper; Suzanne C Danhauer
Journal:  South Med J       Date:  2005-03       Impact factor: 0.954

3.  An exploratory study of musical emotions and psychophysiology.

Authors:  C L Krumhansl
Journal:  Can J Exp Psychol       Date:  1997-12

4.  Haloperidol and spiperone potentiate murine splenic B cell proliferation.

Authors:  Y Liu; S A Wolfe
Journal:  Immunopharmacology       Date:  1996-09

5.  Haloperidol treatments increased macrophage activity in male and female rats: influence of corticosterone and prolactin serum levels.

Authors:  G A Lourenço; V A C Dorce; J Palermo-Neto
Journal:  Eur Neuropsychopharmacol       Date:  2005-01-28       Impact factor: 4.600

6.  Music and methamphetamine: conditioned cue-induced increases in locomotor activity and dopamine release in rats.

Authors:  J E Polston; H Y Rubbinaccio; J T Morra; E M Sell; S D Glick
Journal:  Pharmacol Biochem Behav       Date:  2010-12-09       Impact factor: 3.533

7.  The rewards of music listening: response and physiological connectivity of the mesolimbic system.

Authors:  V Menon; D J Levitin
Journal:  Neuroimage       Date:  2005-07-14       Impact factor: 6.556

8.  Music improves dopaminergic neurotransmission: demonstration based on the effect of music on blood pressure regulation.

Authors:  Den'etsu Sutoo; Kayo Akiyama
Journal:  Brain Res       Date:  2004-08-06       Impact factor: 3.252

9.  Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Shrinivas K Kulkarni
Journal:  Pharmacol Biochem Behav       Date:  2008-08-28       Impact factor: 3.533

10.  Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.

Authors:  Michael Ritsner; Rachel Maayan; Anatoly Gibel; Rael D Strous; Ilan Modai; Abraham Weizman
Journal:  Eur Neuropsychopharmacol       Date:  2004-08       Impact factor: 4.600

View more
  4 in total

1.  Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period.

Authors:  Siamak Sheikhi; Ehsan Saboory
Journal:  Cell J       Date:  2015-01-13       Impact factor: 2.479

2.  Mobile Software as a Medical Device (SaMD) for the Treatment of Epilepsy: Development of Digital Therapeutics Comprising Behavioral and Music-Based Interventions for Neurological Disorders.

Authors:  Pegah Afra; Carol S Bruggers; Matthew Sweney; Lilly Fagatele; Fareeha Alavi; Michael Greenwald; Merodean Huntsman; Khanhly Nguyen; Jeremiah K Jones; David Shantz; Grzegorz Bulaj
Journal:  Front Hum Neurosci       Date:  2018-05-01       Impact factor: 3.169

Review 3.  Combining non-pharmacological treatments with pharmacotherapies for neurological disorders: a unique interface of the brain, drug-device, and intellectual property.

Authors:  Grzegorz Bulaj
Journal:  Front Neurol       Date:  2014-07-14       Impact factor: 4.003

Review 4.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.